In this video, Motley Fool health care analyst Brenton Flynn highlights a couple of emerging trends that medical technology investors should be watching. The first thing he has his eye on is a new procedure called renal denervation, a method to treat patients with hypertension who don't respond to medication. His second area to watch is how different pharmaceutical and biotech companies push into emerging markets, and how they address the need for more value-oriented solutions in these areas.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
2 Must-Watch Medical Technology Trends
NYSE: MDT
Medtronic

2 things every medical technology investor should have their eye on right now.
Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson, Medtronic, and St. Jude Medical. Motley Fool newsletter services recommend Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned




*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.